BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231106
DTEND;VALUE=DATE:20231110
DTSTAMP:20260516T074837
CREATED:20230628T105940Z
LAST-MODIFIED:20230628T105940Z
UID:37371-1699228800-1699574399@www.pharmajournalist.com
SUMMARY:5th Gene Therapy for Neurological Disorders Summit
DESCRIPTION:Accelerating More Transformative Gene Therapies for CNS Disorders \nDespite a challenging 2022 for Gene Therapy developers targeting the CNS\, the recent approvals of Skysona by bluebird bio and Upstaza by PTC Therapeutics have validated the potential that gene therapies can act as transformative medicines within the CNS community. \nThe 5th Gene Therapy for Neurological Disorders Summit is your comprehensive 4-day event to stay ahead of cutting-edge developments\, overcome delivery challenges\, address translational bottlenecks\, and create a bulletproof clinical development strategy\, to propel the next wave of CNS gene therapies forward. \nThis summit will unite 200+ gene therapy and neurology leaders with a program designed to cater to everyone from Discovery through to Clinical Development; this is your only opportunity for a cover-to-cover discussion full of need-to-know and practical insights. \nNow that the neurological gene therapy field has been given a renewed sense of direction\, this is the opportunity for the community to capitalize on the start of a new wave of innovation and optimize the potential for gene therapies targeting neurological disorders. \nTo know more visit: https://ter.li/iblyl1
URL:https://www.pharmajournalist.com/event/5th-gene-therapy-for-neurological-disorders-summit/
LOCATION:Boston Park Plaza\, 50 Park Plaza\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231107
DTEND;VALUE=DATE:20231110
DTSTAMP:20260516T074837
CREATED:20231002T095350Z
LAST-MODIFIED:20231002T095350Z
UID:37885-1699315200-1699574399@www.pharmajournalist.com
SUMMARY:7th Microbiome Movement – Human Nutrition Summit
DESCRIPTION:The 7th Microbiome Movement – Human Nutrition Summit will unite 100+ human nutrition leaders this November in Livingston\, NJ to optimize product development and consumer acceptance of microbiome-based food and nutritional products. Join the only industry led meeting dedicated to moving the needle on scientifically validated\, microbiome modulating\, nutritional product development. \nFrom developing pre-\, pro-\, or post-biotics\, functional food\, microbiome modulating ingredients\, to other interventions that provide microbial-mediated health benefits\, this meeting offers unrivalled opportunities for those working in the microbiome human nutrition space. \nJoin us in Livingston\, NJ\, this November to hear invaluable insights from the likes of Bifidice\, Danone\, Holobiome\, ADM\, Immune Biome\, and more! \nView the full event guide here: https://ter.li/2ppxtz \nOffering earlybird rates\, exclusive group discounts and a brand-new\, post-conference consumer focus day\, now is the time to register. Don’t miss out\, secure your place now: https://ter.li/8algsb
URL:https://www.pharmajournalist.com/event/7th-microbiome-movement-human-nutrition-summit/
LOCATION:Westminster Hotel\, 550 W Mt Pleasant Ave\, Livingston\, NJ\, 07039\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR